Recent changes
Sunday, March 15, 2026
NIH Privacy Act Implementation Final Rule
The National Institutes of Health (NIH) has published a final rule implementing exemptions for a new Privacy Act system of records, 'NIH Police Records.' This rule exempts certain law enforcement investigatory materials from specific Privacy Act requirements to protect ongoing investigations and sources.
NIH Amends Clinical Trials Registration and Results Submission Rule
The National Institutes of Health (NIH) has issued a final rule making a technical amendment to its clinical trials registration and results submission regulation. This amendment updates the URL for accessing information on formatting and submission procedures from the old prsinfo.clinicaltrials.gov to the new clinicaltrials.gov website. The change is effective December 9, 2024.
NIH Terminates Minority Biomedical Research Support Program
The Department of Health and Human Services (HHS), through the National Institutes of Health (NIH), is repealing the regulation for the Minority Biomedical Research Support (MBRS) program. This action is effective September 25, 2025, and aligns with recent Supreme Court decisions and executive orders concerning discrimination and DEI programs.
NIH Delays Effective Date for Privacy Act Exemptions
The National Institutes of Health (NIH) has further delayed the effective date for a final rule concerning Privacy Act exemptions for its police records. The effective date is now May 5, 2025, extended from the previously scheduled March 21, 2025.
NIH Delays Effective Date for Privacy Act Rule
The National Institutes of Health (NIH) has delayed the effective date of a final rule concerning a new Privacy Act system of records. The rule, originally set to take effect on February 18, 2025, is now delayed until March 21, 2025, in accordance with a presidential memorandum.
Friday, March 13, 2026
NIH Reminder: IRB Approval Certification Required Before Award
The National Institutes of Health (NIH) issued a notice reminding the extramural research community that certification of Institutional Review Board (IRB) approval is required before award for nonexempt human subjects research. Funds cannot be used for such research without this certification, which must be the date of final IRB approval, not pending or expired.
NIH Extends Common Forms Timeline for Biographical Sketch and Other Support
The National Institutes of Health (NIH) has extended the leniency period for implementing Common Forms for Biographical Sketch and Current and Pending (Other) Support until May 2026. This notice adjusts the original January 25, 2026 deadline to allow the extramural community more time for adoption and compliance.
NIH Removes Advanced Permission for Conference Grant Applications
The National Institutes of Health (NIH) has removed the requirement for advanced permission for conference grant applications under activity codes R13 and U13. This change aims to reduce administrative burden for applicants, with modifications to the NIH Grants Policy Statement and relevant NOFOs forthcoming.
NIH Correction: Salary Limitation for Grants and Cooperative Agreements FY 2026
The National Institutes of Health (NIH) issued a correction to its guidance on salary limitations for grants and cooperative agreements for Fiscal Year 2026. The correction adjusts the effective date for the Executive Level II salary limitation of $228,000 from January 11, 2026, to January 1, 2026.
NIH Notice: Expiration of PAR-25-326 Ultra-Rare Gene Therapy Network Access
The National Institute of Neurological Disorders and Stroke (NINDS) issued a notice announcing the immediate expiration of Funding Opportunity Announcement PAR-25-326 for Ultra-Rare Gene-based Therapy (URGenT) Network Resource Access. No further applications will be accepted under this announcement.
Last 7 days
Most active sources
Browse Categories
Activity
Get daily alerts
Morning digest delivered to your inbox. Free.
Free. Unsubscribe anytime.
4 monitored sources
Get NIH alerts
Daily digest of NIH regulatory changes. AI-summarized, no noise.
Free. Unsubscribe anytime.